Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Aftertreated polymer
Reexamination Certificate
2006-03-28
2006-03-28
Webman, Edward J. (Department: 1616)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Aftertreated polymer
C525S054100, C525S403000, C530S816000
Reexamination Certificate
active
07018624
ABSTRACT:
A degradable PEG hydrogel is described that, upon hydrolysis, releases conjugates of substantially non-peptidic polymers and biologically active molecules. For example, PEG and protein conjugates can be released in vivo from the hydrogels for therapeutic application.
REFERENCES:
patent: 3419006 (1968-12-01), King
patent: 3963805 (1976-06-01), Chu
patent: 4179337 (1979-12-01), Davis et al.
patent: 4424311 (1984-01-01), Nagaoka et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4894238 (1990-01-01), Embry et al.
patent: 5192743 (1993-03-01), Hsu et al.
patent: 5410016 (1995-04-01), Hubbell et al.
patent: 5567422 (1996-10-01), Greenwald
patent: 5607687 (1997-03-01), Bezwada et al.
patent: 5610241 (1997-03-01), Lee et al.
patent: 5618528 (1997-04-01), Cooper et al.
patent: 5730968 (1998-03-01), Butterfield et al.
patent: 5874500 (1999-02-01), Rhee et al.
patent: 6051648 (2000-04-01), Rhee et al.
patent: 6166130 (2000-12-01), Rhee et al.
patent: 6258351 (2001-07-01), Harris
patent: 6323278 (2001-11-01), Rhee et al.
patent: 6348558 (2002-02-01), Harris et al.
patent: 6362276 (2002-03-01), Harris et al.
patent: 6515100 (2003-02-01), Harris
patent: 2002/0013408 (2002-01-01), Rhee et al.
patent: 2002/0064546 (2002-05-01), Harris
patent: 0 473 268 (1992-03-01), None
patent: 0 593 284 (1994-04-01), None
patent: 0 771 832 (1997-05-01), None
patent: 0 794 211 (1997-09-01), None
patent: 0 841 360 (1998-05-01), None
patent: WO 92/00748 (1992-01-01), None
patent: WO 93/24476 (1993-12-01), None
patent: WO 94/03155 (1994-02-01), None
patent: WO 95/35093 (1995-12-01), None
patent: WO 96/21469 (1996-07-01), None
Gayet et al., “High Water Content BSA-PEG Hydrogel for Controlled Release Device: Evaluation of the Drug Release Properties”,Journal of Controlled Release, 1996, pp. 177-184, vol. 38.
Greenwald et al., “Highly Water Soluble Taxol Derivatives: 7-Polyethylene Glycol Carbamates and Carbonates”,J. Org. Chem., 1995, pp. 331-336, vol. 60, No. 2.
J.M. Harris, Ed., “Introduction to Biotechnical and Biomedical Applications of Poly(Ethylene Glycol)”,Plenum, New York, 1992, pp. 1-11.
Jeong et al., “Biodegradable Block Copolymers As Injectable Drug-Delivery Systems”,Nature, 1997, pp. 860-862, vol. 388, No. 28.
Martinez et al, “Branched Poly(Ethylene Glycol) Linkers”,Macromolecular Chemistry And Physics, 1997, pp. 2489-2498, vol. 198, No. 8.
Pitt et al, “Manipulation Of The Rate Of Hydrolysis Of Polymer-Drug Conjugates: The Secondary Structure Of The Polymer”,Journal Of Controlled Release, 1996, pp. 221-229, vol. 39, No. 2.
Sawhney et al., “Bioerodible Hydrogels Based on Photopolymerized Poly(Ethylene Glycol)-co-poly(α-hydroxy acid) Diacrylate Macromers”,Macromolecules, 1993, pp. 581-587, vol. 26, No. 4.
Zalipsky, “Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates”,Bioconjugate Chem., 1995, pp. 150-165, vol. 6, No. 2.
Debio Recherche Pharmaceutique S.A.
Webman Edward J.
LandOfFree
Delivery of poly(ethylene glycol)-modified molecules from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delivery of poly(ethylene glycol)-modified molecules from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery of poly(ethylene glycol)-modified molecules from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3578218